Tuesday, Dec 26, 2023 · SEC filings

What the smart money revealed on Dec 26

Real insider buys30insiders · $7.44M
Real insider sales50insiders · $70.9M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

242 insider filings came in. We hid 40 planned (10b5-1) sellers and 99 people whose filings were routine, like grants and tax withholding.

group

3 insiders at Southland (SLND) bought $118K of stock

Roles: CEO, Executive VP, Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Dec 21–26
$118K
trending_up

Syros Pharmaceuticals (SYRS) Director Srinivas Akkaraju bought $4M

904,977 shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 7 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 3 of 7 beat Traded Dec 21
$4M
trending_up

HighPeak Energy (HPK) CEO Jack Hightower bought $2.16M

150,442 shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 3 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 0 of 3 beat Traded Dec 21–22
$2.16M
trending_up

Kimbell Royalty Partners (KRP) Director T. Scott Martin bought $461K

30,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Dec 21–22
$461K
trending_up

Range Impact (RNGE) CEO Michael Cavanaugh bought $150K

1M shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Dec 21
$150K
trending_down

Adobe (ADBE) Chair and CEO Shantanu Narayen sold $19.1M

Not marked as a planned 10b5-1 sale. Sold 8% of the shares they held directly. Still holds 377,928 shares.

Real sale Form 4 Traded Dec 22
$19.1M
trending_down

Vornado Realty Trust (VNO) Director Michael Fascitelli sold $17.7M

Not marked as a planned 10b5-1 sale. Sold 38% of the shares they held directly. Still holds 969,491 shares.

Real sale Form 4 Sold 38% of stake Traded Dec 21–22
$17.7M
trending_down

Waste Connections (WCN) SR VP Business Development Philip Rivard sold $745K

Not marked as a planned 10b5-1 sale. Sold every share held directly.

Real sale Form 4 Sold 100% of stake Traded Dec 21
$745K
Show 23 more real buys
NMTC Neuroone Medical Technologies · COO Christopher Volker · Traded Dec 21
$105K
RNGE Range Impact · Director Edward Feighan · Traded Dec 21
$100K
CAUD Collective Audience · Director Brent Suen · Traded Dec 21–26
$90.3K
FDX FedEx · Director Amy Lane · Traded Dec 26
$50.6K
DHY Credit Suisse High Yield Bond Fund · Chief Investment Officer Thomas Flannery · Traded Dec 21
$39.2K
CAUD Collective Audience · CEO Peter Bordes Jr. · Traded Dec 26
$24.8K
BGMS Cyclacel Pharmaceuticals · President and CEO Spiro Rombotis · Traded Dec 21
$20.2K
TGEN Tecogen · Director John Hatsopoulos · Traded Dec 22
$20K
TPL Texas Pacific Land · Director Murray Stahl · Traded Dec 22
$19.4K
HYB New America High Income Fund · Director Luis Viceira · Traded Dec 21
$14K
CSBR Champions Oncology · Director Daniel Mendelson · Traded Dec 21
$12.3K
PARA Banzai International · CEO Joseph Davy · Traded Dec 21
$10K
BCAB BioAtla · Director Sylvia McBrinn · Traded Dec 26
$9.32K
NXGL Nexgel · Director steven glassman · Traded Dec 22
$8.55K
BGMS Cyclacel Pharmaceuticals · E. VP Paul McBarron · Traded Dec 21
$6.26K
SYRA Syra Health · President and Chair Sandeep Allam · Traded Nov 28–Dec 14 · Filed late
$4.99K
HNNA Hennessy Advisors · CEO Neil Hennessy · Traded Dec 18
$3.89K
GOVX GeoVax Labs · Chief Medical Officer Kelly McKee Jr. · Traded Dec 22
$2.5K
STER Sterling Check · Director Adrian Jones · Traded Dec 22
$2.11K
OPNW VerifyMe · CEO Adam Stedham · Traded Dec 21–22
$2.03K
CATX Perspective Therapeutics · Director Robert Williamson III · Traded Dec 21
$1.21K
SYRA Syra Health · CEO Deepika Vuppalanchi · Traded Dec 4 · Filed late
$498
RCG RENN Fund · President and CEO Murray Stahl · Traded Dec 22
$140
Show 47 more real sales
GES Guess · Chief Creative Officer Paul Marciano · Traded Dec 21
$7.07M
RBLX Roblox · President and CEO David Baszucki · Traded Dec 22
$4.78M
AMAT Applied Materials · Senior Vice President Omkaram Nalamasu · Traded Dec 22
$3.77M
FDS FactSet Research Systems · EVP Rachel Stern · Traded Dec 21
$2.87M
FDS FactSet Research Systems · EVP Robert Robie · Traded Dec 21
$2.08M
ADBE Adobe · EVP and CFO Daniel Durn · Traded Dec 22
$1.79M
COUR Coursera · President and CEO Jeffrey Maggioncalda · Traded Dec 21–26
$1.49M
MOV Movado Group · CFO Sallie Demarsilis · Traded Dec 21–22
$1.38M
NXST Nexstar Media Group · EVP Blake Russell · Traded Dec 26
$820K
NDSN Nordson · Executive Vice President Joseph Kelley · Traded Dec 22
$729K
COR Cencora · EVP and Chief Strategy Officer Leslie Donato · Traded Dec 21
$687K
CAL Caleres · SVP Mark Schmitt · Traded Dec 21
$655K
KEX Kirby · President-Kirby Inland Marine Christian O'Neil · Traded Dec 21
$552K
FROG JFrog · CEO Ben Shlomi · Traded Dec 22
$422K
LEGH Legacy Housing · Director Curtis Hodgson · Traded Dec 26
$422K
VRNS Varonis Systems · SVP of Worldwide Sales James O'Boyle · Traded Dec 26
$358K
CECO CECO Environmental · CEO Todd Gleason · Traded Dec 21
$306K
RLJ RLJ Lodging Trust · Director Arthur Collins · Traded Dec 22
$298K
NXST Nexstar Media Group · Senior Advisor Thomas Carter · Traded Dec 22
$288K
CRM Salesforce · Pres/Chief Engineering Officer Srinivas Tallapragada · Traded Dec 26
$250K
CRM Salesforce · Co-Founder and CTO Parker Harris · Traded Dec 26
$250K
CBSTF Cannabist · CEO Nicholas Vita · Traded Dec 20–22
$231K
SYBT Stock Yards Bancorp · Sr. Executive Vice President Kathy Thompson · Traded Dec 21
$202K
RXST RxSight · COO Ilya Goldshleger · Traded Dec 22
$200K
LGIH LGI Homes · Director Steven Smith · Traded Dec 21
$197K
ACN Accenture · Director Paula Price · Traded Dec 21
$190K
LCPMX Lind Capital Partners Municipal Credit Income Fund · Director Richard Adler · Traded Dec 1 · Filed late
$181K
ALG Alamo Group · EVP Vegetation Management Richard Raborn · Traded Dec 22
$129K
EPR EPR Properties · Director Peter Brown · Traded Dec 22
$122K
ELVN Enliven Therapeutics · President and CEO Samuel Kintz · Traded Dec 21–22
$107K
ACEL Accel Entertainment · Secretary Derek Harmer · Traded Dec 26
$102K
EPR EPR Properties · SVP and CAO Tonya Mater · Traded Dec 26
$72.8K
OKE Oneok · Director Eduardo Rodriguez · Traded Dec 22
$56.2K
RXST RxSight · Chief Commercial Officer Eric Weinberg · Traded Dec 22
$51.4K
DFTX Mind Medicine (MindMed) · CEO Robert Barrow · Traded Dec 26
$48.1K
GEVO Gevo · Chief Mktg Cust and Brnd Officer Andrew Shafer · Traded Dec 26
$30.7K
DFTX Mind Medicine (MindMed) · Chief Medical Officer Dan Karlin · Traded Dec 26
$24.6K
DFTX Mind Medicine (MindMed) · CFO Schond Greenway · Traded Dec 26
$20.5K
NMTC Neuroone Medical Technologies · Business Development Director Mark Christianson · Traded Dec 21–22
$16.4K
CRM Salesforce · EVP and Chief Accounting Officer Sundeep Reddy · Traded Dec 26
$14.9K
AI C3.ai · SVP and CFO Juho Parkkinen · Traded Dec 26
$11.7K
SOUN Soundhound Ai · CTO Timothy Stonehocker · Traded Dec 21
$10.7K
SONX Sonendo · President and CEO Bjarne Bergheim · Traded Dec 25
$3.54K
STER Sterling Check · Director Adrian Jones · Traded Dec 13 · Filed late
$2.13K
SONX Sonendo · CFO Michael Watts · Traded Dec 25
$1.78K
SONX Sonendo · Chief Talent Officer Roy Chen · Traded Dec 25
$693
WINV WinVest Acquisition · Director Barrie Zesiger · Traded Dec 22
$280

13F season

Holdings as of Sep 30, 2023 were due Nov 14

40 funds have filed. 40 filed for the quarter before.

Biggest real insider buys, Dec 20–26

Open-market buys by officers and directors, filed in the 7 days up to Dec 26.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist